Internal Medicine, Cardiovascular Disease · Melbourne, FL
NPI
1881670479
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1223 Gateway Dr, Suite 2e
Melbourne, FL, 32901
Phone (321) 725-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$428K
7,008 services
Medicare patients, 2024
1,258
Average age 77
Drug cost, 2024
$1.3M
4,629 prescriptions
Company payments, 2025
$68.02
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas W Swain was code 99214 (office e&m - established), 1,039 times for 662 patients. In total Thomas W Swain billed 7,008 services in 78 codes, and Medicare paid $428K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,039 | 662 | $92.62 | $96K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 898 | 596 | $12.71 | $11K |
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 801 | 14 | $0.47 | $375 |
| 93000 Electrocardiogram | Office | 635 | 532 | $9.78 | $6,211 |
| 93306 Echocardiography (TTE/TEE) | Office | 472 | 462 | $136.56 | $64K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 366 | 93 | $4.99 | $1,828 |
| 93296 External Electrocardiographic Monitoring | Office | 362 | 146 | $13.84 | $5,011 |
| 93294 External Electrocardiographic Monitoring | Office | 249 | 96 | $18.99 | $4,728 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 240 | 121 | $349.67 | $84K |
| 78452 Myocardial Perfusion Scan | Office | 154 | 154 | $320.27 | $49K |
| 93015 Electrocardiogram | Office | 148 | 148 | $47.45 | $7,023 |
| 93298 External Electrocardiographic Monitoring | Office | 144 | 25 | $72.11 | $10K |
| 93227 Electrocardiogram | Office | 141 | 133 | $12.89 | $1,817 |
| 93297 External Electrocardiographic Monitoring | Office | 132 | 58 | $40.19 | $5,305 |
| 99204 Office E&M - New | Office | 125 | 125 | $125.19 | $16K |
By year: 2022 $350K for 9,460 services; 2023 $382K for 13,260 services; 2024 $428K for 7,008 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas W Swain prescribed most often to Medicare patients was Eliquis (Apixaban), with 554 prescriptions and refills. In total Thomas W Swain wrote 4,629 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 554 | 1,065 | 135 | $589K |
| Metoprolol Tartrate Generic | 324 | 894 | 110 | $2,873 |
| Metoprolol Succinate Generic | 256 | 706 | 85 | $5,184 |
| Atorvastatin Calcium Generic | 237 | 657 | 70 | $3,132 |
| Carvedilol Generic | 204 | 542 | 56 | $2,895 |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | 181 | 436 | 69 | $63K |
| Furosemide Generic | 173 | 467 | 63 | $1,399 |
| Losartan Potassium Generic | 168 | 452 | 57 | $3,329 |
| Clopidogrel Clopidogrel Bisulfate | 159 | 456 | 54 | $2,777 |
| Xarelto Rivaroxaban | 132 | 305 | 38 | $162K |
| Amlodipine Besylate Generic | 131 | 375 | 46 | $1,045 |
| Amiodarone Hcl Generic | 112 | 283 | 34 | $2,381 |
| Sotalol Sotalol Hcl | 109 | 310 | 39 | $2,337 |
| Lisinopril Generic | 101 | 298 | 35 | $1,038 |
| Flecainide Acetate Generic | 97 | 235 | 29 | $5,385 |
Brand drugs: 1,155 claims; generic drugs: 3,474 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas W Swain $68.02 ($68.02 in general payments such as food, travel and fees) from 2 companies. The largest payer was CVRx, Inc. with $48.9.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.